Sign inGet started

KAILIAN VAUGHN M

Insider CIK 1180429 · CHMA 10% owner · CNAT 10% owner · SNDX 10% owner · PCRX · RDUS 10% owner · TRIV 10% owner · PETX 10% owner · VSTM · CERC 10% owner · EPZM 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RDUS Radius Health, Inc. J Other2016-09-272016-09-29713,849— $01,427,698SEC↗
SNDX Syndax Pharmaceuticals Inc C Conversion deriv2016-03-082016-03-09312,085— $00SEC↗
SNDX Syndax Pharmaceuticals Inc C Conversion deriv2016-03-082016-03-091,138,210— $00SEC↗
SNDX Syndax Pharmaceuticals Inc C Conversion deriv2016-03-082016-03-09718,396— $00SEC↗
SNDX Syndax Pharmaceuticals Inc C Conversion2016-03-082016-03-09718,396— $01,856,606SEC↗
SNDX Syndax Pharmaceuticals Inc C Conversion2016-03-082016-03-091,138,210— $01,138,210SEC↗
SNDX Syndax Pharmaceuticals Inc C Conversion2016-03-082016-03-09312,085— $02,168,691SEC↗
CERC Cerecor Inc. C Conversion deriv2015-10-202015-10-2016,672,224— $00SEC↗
CERC Cerecor Inc. C Conversion2015-10-202015-10-20595,436— $0595,436SEC↗
CHMA CHIASMA, INC C Conversion deriv2015-07-212015-07-2195,225— $00SEC↗
CHMA CHIASMA, INC C Conversion deriv2015-07-212015-07-2113,000,000— $00SEC↗
CHMA CHIASMA, INC C Conversion deriv2015-07-212015-07-2122,721,988— $00SEC↗
CHMA CHIASMA, INC C Conversion deriv2015-07-212015-07-2116,066,669— $00SEC↗
CHMA CHIASMA, INC C Conversion2015-07-212015-07-2110,426— $010,426SEC↗
CHMA CHIASMA, INC C Conversion2015-07-212015-07-212,488,171— $02,498,597SEC↗
CHMA CHIASMA, INC C Conversion2015-07-212015-07-211,423,566— $05,681,544SEC↗
CHMA CHIASMA, INC C Conversion2015-07-212015-07-211,759,381— $04,257,978SEC↗
RDUS Radius Health, Inc. C Conversion deriv2014-06-062014-06-1071,638— $00SEC↗
RDUS Radius Health, Inc. C Conversion deriv2014-06-062014-06-10184,242— $00SEC↗
RDUS Radius Health, Inc. C Conversion deriv2014-06-062014-06-10114,537— $00SEC↗
RDUS Radius Health, Inc. C Conversion2014-06-062014-06-10883,993— $01,433,541SEC↗
RDUS Radius Health, Inc. C Conversion2014-06-062014-06-10314,204— $01,747,745SEC↗
RDUS Radius Health, Inc. J Other2014-06-062014-06-10393,802— $02,141,547SEC↗
RDUS Radius Health, Inc. C Conversion2014-06-062014-06-10549,548— $0549,548SEC↗
TRIV TriVascular Technologies, C Conversion deriv2014-04-222014-04-231,516,122— $00SEC↗
TRIV TriVascular Technologies, C Conversion deriv2014-04-222014-04-2315,400,411— $00SEC↗
TRIV TriVascular Technologies, C Conversion deriv2014-04-222014-04-2337,369— $037,369SEC↗
TRIV TriVascular Technologies, C Conversion deriv2014-04-222014-04-2320,757,635— $00SEC↗
TRIV TriVascular Technologies, C Conversion deriv2014-04-222014-04-236,000,000— $00SEC↗
TRIV TriVascular Technologies, C Conversion deriv2014-04-222014-04-2310,266,940— $00SEC↗
TRIV TriVascular Technologies, C Conversion deriv2014-04-222014-04-232,947,605— $00SEC↗
TRIV TriVascular Technologies, C Conversion2014-04-222014-04-23114,942— $01,144,027SEC↗
TRIV TriVascular Technologies, C Conversion2014-04-222014-04-23230,756— $01,029,085SEC↗
TRIV TriVascular Technologies, C Conversion2014-04-222014-04-23798,329— $0798,329SEC↗
TRIV TriVascular Technologies, C Conversion2014-04-222014-04-23253,066— $01,776,692SEC↗
TRIV TriVascular Technologies, C Conversion2014-04-222014-04-23379,599— $01,523,626SEC↗
PETX ARATANA THERAPEUTICS, INC. S Sale2014-03-102014-03-12600,000$20.02 $12.01M2,751,048SEC↗
PETX ARATANA THERAPEUTICS, INC. J Other2014-03-032014-03-0520,876— $038,386SEC↗
PETX ARATANA THERAPEUTICS, INC. J Other2014-03-032014-03-0515,310— $017,937SEC↗
PETX ARATANA THERAPEUTICS, INC. J Other2014-03-032014-03-0520,876— $022,767SEC↗
PETX ARATANA THERAPEUTICS, INC. J Other2014-03-032014-03-0512,247— $012,393SEC↗
PETX ARATANA THERAPEUTICS, INC. J Other2014-03-032014-03-0520,876— $026,713SEC↗
PETX ARATANA THERAPEUTICS, INC. J Other2014-03-032014-03-051,000,000— $03,351,048SEC↗
PETX ARATANA THERAPEUTICS, INC. J Other2014-03-032014-03-0537,117— $037,117SEC↗
EPZM Epizyme, Inc. S Sale2014-02-102014-02-11466,666$29.25 $13.65M2,413,819SEC↗
CNAT Conatus Pharmaceuticals In C Conversion deriv2013-07-302013-08-01265,837— $00SEC↗
CNAT Conatus Pharmaceuticals In C Conversion deriv2013-07-302013-08-0132,220— $032,220SEC↗
CNAT Conatus Pharmaceuticals In C Conversion deriv2013-07-302013-08-018,333,334— $00SEC↗
CNAT Conatus Pharmaceuticals In J Other2013-07-302013-08-0116,716$11.00 $183.9K1,026,815SEC↗
CNAT Conatus Pharmaceuticals In P Buy2013-07-302013-08-01165,265$11.00 $1.82M1,192,080SEC↗
CNAT Conatus Pharmaceuticals In C Conversion2013-07-302013-08-011,010,099— $01,010,099SEC↗
PETX ARATANA THERAPEUTICS, INC. C Conversion deriv2013-07-022013-07-02375,000— $00SEC↗
PETX ARATANA THERAPEUTICS, INC. C Conversion deriv2013-07-022013-07-021,333,333— $00SEC↗
PETX ARATANA THERAPEUTICS, INC. C Conversion deriv2013-07-022013-07-024,000,000— $00SEC↗
PETX ARATANA THERAPEUTICS, INC. P Buy2013-07-022013-07-02500,000$6.00 $3.00M4,351,050SEC↗
PETX ARATANA THERAPEUTICS, INC. C Conversion2013-07-022013-07-02225,631— $03,851,050SEC↗
PETX ARATANA THERAPEUTICS, INC. C Conversion2013-07-022013-07-02802,246— $03,625,419SEC↗
PETX ARATANA THERAPEUTICS, INC. C Conversion2013-07-022013-07-022,406,739— $02,823,173SEC↗
EPZM Epizyme, Inc. C Conversion deriv2013-06-052013-06-061,176,472— $00SEC↗
EPZM Epizyme, Inc. C Conversion deriv2013-06-052013-06-066,930,000— $00SEC↗
EPZM Epizyme, Inc. C Conversion2013-06-052013-06-062,309,998— $02,488,329SEC↗
EPZM Epizyme, Inc. C Conversion2013-06-052013-06-06392,156— $02,880,485SEC↗
RDUS Radius Health, Inc. P Buy deriv2013-04-232013-04-30179,095$6.14 $1.10M179,095SEC↗
RDUS Radius Health, Inc. P Buy deriv2013-04-232013-04-3071,638$61.42 $4.40M71,638SEC↗
PCRX Pacira Pharmaceuticals, In S Sale2013-03-112013-03-13500,000$27.86 $13.93M2,790,479SEC↗
VSTM Verastem, Inc. C Conversion deriv2012-02-012012-02-03266,666— $00SEC↗
VSTM Verastem, Inc. C Conversion deriv2012-02-012012-02-032,500,000— $00SEC↗
VSTM Verastem, Inc. C Conversion deriv2012-02-012012-02-034,000,000— $00SEC↗
VSTM Verastem, Inc. C Conversion2012-02-012012-02-031,933,333— $01,933,333SEC↗
VSTM Verastem, Inc. P Buy2012-02-012012-02-03100,000$10.00 $1.00M2,033,333SEC↗